[1]戈朝晖,王自立,魏敏吉,等.脊柱结核病灶中抗痨药物浓度的测定[J].中华骨科杂志,2005,25(2):36-40
[2]Wang Z, Ge Z, Jin W, et al. Treatment of spinal tuberculosis with ultrashort-course chemotherapy in conjunction with partial excision of pathologic vertebrae. Spine J. 2007;7(6):671-681.
[3]德向研,施建党,王自立,等.载三联抗结核药硫酸钙氨基酸聚合物人工骨体内缓释研究[J].中国脊柱脊髓杂志, 2013, 23(6)531-536.
[4]刘海涛,施建党,王骞,等.载三联抗结核药物硫酸钙聚氨基酸人工材料体外缓释性能的观察[J].中国脊柱脊髓杂志, 2015,25(3)239-244.
[5]张峻山,王自立,施建党,等.复合三联抗结核药人工缓释材料体外抗结核性能[J].中国脊柱脊髓杂志, 2014,12(6): 380-384.
[6]刘海涛,施建党,王骞,等.硫酸钙/聚氨基酸复合三联抗痨药人工缓释材料的制备及物理性能的测定[J],中国矫形外科杂志,2015,23(21)1984-1988.
[7]闫军法,王骞,施建党,等.涂饰PLGA载三联抗痨药人工骨的体外释药研究[J].宁夏医科大学学报, 2015,37(6): 661-664.
[8]Geng GQ, Wang Q, Shi JD, et al. Establishment of a New Zealand Rabbit Modelof Spinal Tuberculosis. J Spinal Disord Tech. 2015;3(28):e140-e145.
[9]Liu X, Jia W, Wang H, et al. Establishment of a rabbit model of spinal tuberculosis using Mycobacterium tuberculosis strain H37Rv. Jpn J Infect Dis. 2015;68(2): 89-97.
[10]Blatt RJ, Clark AN, Courtney J, et al. Automated quantitative analysis of angiogenesis in the rat aorta model using Image-Pro Plus 4.1. Comput Methods Programs Biomed. 2004;75(1):75-79.
[11]Gao Y, Zuo J, bou-chacra N, et al. In vitro release kinetics of antituberculosis drugs from nanoparticles assessed using a modified dissolution apparatus. Biomed Res Int. 2013;2013:136590.
[12]Ruckh TT, Oldinski RA, Carroll DA. antimicrobial effects of nanofiber poly(caprolactone) tissue scaffolds releasing rifampicin. J Mater Sci Mater Med. 2012; 23(6):1411-1420.
[13]费正奇,胡藴玉.抗骨结核缓释药物:载体材料的选择[J].中国组织工程研究,2015,19(21):3387-3391. |